United States· US:69097-828_4d3f7e7a-ed61-4df6-bc45-f38fb4117406
Quinapril and Hydrochlorothiazide 10/12.5
A medicinal product containing quinapril hydrochloride; hydrochlorothiazide, registered in United States by Cipla USA Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- QUINAPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
- Manufacturer
- Cipla USA Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1169097-828-05
- ndc11690978280590 TABLET in 1 BOTTLE (69097-828-05)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Quinapril hydrochloride; hydrochlorothiazide in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaAURO-QUINAPRIL HCTZAURO PHARMA INC
- FinlandAccupro CompPfizer Oy
- United KingdomAccuretic 10mg/12.5mg tabletsMawdsley-Brooks & Company Ltd
- ItalyQUINAPRIL E IDROCLOROTIAZIDE MYLAN GENERICSMYLAN S.P.A.
- FranceACUILIX 20 mg/12,5 mg, comprimé pelliculé sécablePFIZER HOLDING FRANCE
- SpainBICETIL 20 mg / 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULALaboratorios Menarini S.A.
- GermanyQuinaplusAliud Pharma Gmbh
- SwedenKinoprilam comp 10 mg/12,5 mg Filmdragerad tablettSTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Quinaplus, Quinapril/Hydrochlorothiazid Aurobindo
- Spain · Lidaltrin-Diu
- France · Acuilix, Quinapril Hydrochlorothiazide Eg
- Italy · Quinapril E Idroclorotiazide Mylan Generics, Quinapril Idroclorotiazide Aurobindo
- Netherlands · Quinapril/Hct Cf
- Sweden · Kinoprilam Comp
- Slovakia · Stadapress
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e70a9feb-87ee-4d37-b64d-7d0caefe2281 GET /v1/drugs/e70a9feb-87ee-4d37-b64d-7d0caefe2281?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10; 12.5",
"substance": "QUINAPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE",
"productndc": "69097-828",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA201356",
"marketing_category": "ANDA"
}See everything about quinapril hydrochloride; hydrochlorothiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.